Bilenker, Engelman create Treeline Biosciences
Josh Bilenker, M.D., and Jeff Engelman M.D., Ph.D., have joined forces to create a new cancer biotech, tapping their combined considerable experience to find new...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Josh Bilenker, M.D., and Jeff Engelman M.D., Ph.D., have joined forces to create a new cancer biotech, tapping their combined considerable experience to find new...
CaroGen Corporation has been awarded a $3 million Phase 2b SBIR grant from the National Institutes of Health (NIH) to advance its lead clinical candidate...
Astrocyte Pharmaceuticals reports the completion of a Series A financing that raised $6.0M. Astrocyte is progressing its lead development candidate AST-004 to address the unmet...
BioCT welcomes Cynthia D. Green, PhD, MBA, to its Board of Directors. Cyndi is currently Managing Director at Connecticut Innovations, the state’s strategic venture capital arm...
UConn researcher Paulo Verardi, associate professor of pathobiology and veterinary science in the College of Agriculture, Health and Natural Resources, has demonstrated the success of...
In 2020, diversity and inclusion was thrust front and center of the conversation for many organizations in the life sciences industry. Hard conversations began with...
InveniAI® reports a multi-target drug discovery collaboration with Shionogi & Co. The multi-year collaboration will combine InveniAI’s AI platform, AlphaMeld®, to research and validate targets...
MediSynergics reports that the company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ketamine derivative patent...
Tesseract Health reports it has raised $80 million in an oversubscribed Series B financing round to advance the development of its Tesseract iC eye-imaging diagnostic technology...
CaroGen’s lead product is an immunotherapy that targets Hepatitis B. The company is also working on immunotherapies for ovarian cancer and for colorectal cancer. Bijan Almassian is...